CLINICAL_TRIALS
trial_result
· 2021-08-23
Clinical Trial Update: Safety of SPD465 in Treating Adults With ADHD. [Phase 3]
Summary
Phase 3 trial update on SPD465 (attention-deficit/hyperactivity disorder) assessing safety in adults; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 3 | Status: COMPLETED